LYELL IMMUNOPHARMA INC (LYEL) Institutional Ownership and Insiders Activity

LYELL IMMUNOPHARMA INC (LYEL) is widely held by institutional investors, with 1 firm reporting positions valued at approximately $9.72M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Decheng Capital Llc is the largest disclosed holder, reporting approximately $9.72M in LYEL holdings in its latest filing.

Institutional ownership remains highly concentrated, with Decheng Capital Llc representing the majority of disclosed value.

Recent insider activity includes 13 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.